H-TYR-SER-PRO-TRP-THR-ASN-PHE-OH
CAS228544-21-6
H-TYR-SER-PRO-TRP-THR-ASN-PHE-OH (CAS 228544-21-6, C45H55N9O12) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 228544-21-6
- Formula
- C45H55N9O12
- Mol. weight
- 913.97 g/mol
Chemical Specifications
Identifiers
| CAS number | 228544-21-6 |
|---|---|
| Product name | H-TYR-SER-PRO-TRP-THR-ASN-PHE-OH |
| Synonyms | H-TYR-SER-PRO-TRP-THR-ASN-PHE-OH; RIP; RNAIII INHIBITING PEPTIDE; TYR-SER-PRO-TRP-THR-ASN-PHE |
| Molecular formula | C45H55N9O12 |
| Molecular weight | 913.97 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Safety and transport
| Safety Statements | WGK Germany 3 |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of H-TYR-SER-PRO-TRP-THR-ASN-PHE-OH?
The CAS Registry Number of H-TYR-SER-PRO-TRP-THR-ASN-PHE-OH is 228544-21-6. H-TYR-SER-PRO-TRP-THR-ASN-PHE-OH is also known as H-TYR-SER-PRO-TRP-THR-ASN-PHE-OH; RIP; RNAIII INHIBITING PEPTIDE.
What is the molecular formula and molecular weight of H-TYR-SER-PRO-TRP-THR-ASN-PHE-OH?
The molecular formula of H-TYR-SER-PRO-TRP-THR-ASN-PHE-OH is C45H55N9O12, and its molecular weight is 913.97 g/mol.
How can I request a quotation for H-TYR-SER-PRO-TRP-THR-ASN-PHE-OH?
Send an inquiry for H-TYR-SER-PRO-TRP-THR-ASN-PHE-OH (CAS 228544-21-6) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for H-TYR-SER-PRO-TRP-THR-ASN-PHE-OH
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.